InvestSMART

Paragon Care Limited (ASX:PGC)

ALERT: Price-sensitive ASX Announcement for PGC
Current share price for PGC : $0.145 -0.06 (-29.27%)+
Announcement
Release
25 Feb 2026 9:01AM
Price at Release
$0.205
Full Release
download
Summary
Paragon Care Limited, a leading healthcare provider in the Asia Pacific region, announced its financial results for the half-year ended 31 December 2025, reporting a revenue increase of 2.9% to $1.9 billion and a 3.1% rise in underlying EBITDA to $49.0 million. The company continued to execute its 3-2-1 integration strategy and made strategic acquisitions and investments to expand its channel and category offerings. Paragon Care also faced challenges with the Infinity Group, fully providing for a debt expense of $46.4 million. Despite these challenges, the company progressed with its business expansion across Australia and Asia and initiated operations from a new distribution centre in Brisbane. The outlook for FY26 includes a forecasted revenue of $3.6 to $3.7 billion and underlying EBITDA between $97 to $107 million, with continued growth expected in Asian markets.
Key Points
  • Revenue increased by 2.9% to $1.9 billion for HY26.
  • Underlying EBITDA rose by 3.1% to $49.0 million.
  • The company executed strategic acquisitions and investments.
  • Full provision against Infinity Group debt was taken.
  • The 3-2-1 integration strategy is on track for completion in FY26.
  • The new Willawong distribution centre in Brisbane commenced operations.
  • Contract Logistics revenue grew by 47.1% to $235.5 million.
  • Paragon Care's Medical Technology revenue increased by 15.3%.
  • A 5-year contract with the Australian Defence Force was awarded.
  • No interim dividend declared for HY26.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.